Aurobindo Pharma advanced over 3% and touched day’s high of Rs118.50, after the company receives USFDA approvals for Quehapine Fumarate tablets, So far, 0.34 lakh shares have traded on the BSE as against the two-week average volume of 1.53 lakh shares.
Aurobindo Pharma announce that the company has received final approvals from the US Food & Drug Administration ( USFDA) to market Quehapine Fumarate Tablets 25mg, 50mg, 100mg, 150mg, 200mg, 300mg and 400mg (ANDA 091388)
Quetiapine Fumarate Tablets 25mg, 50mg, 100mg, 150mg. 200mg, 300mg and 400mg are the generic equivalent of AstraZeneca LP’s Seroquel® Tablets 25mg, 50mg, 100mg. 150mg, 200mg, 300mg and 400mg. Quebapine Fumarate Tablets are indicated for the treatment of serious psychotic disorders such as Schizophrenia and Bipolar Disorder and falls under the Neurological (CNS) therapeutic category.
The product has been approved out of Unit III facility in Hyderabad, India Aurobindo now has a total of 147 ANDA approvals (118 Final approvals and 29 Tentative approvals) from USFDA
....more info
Aurobindo Pharma announce that the company has received final approvals from the US Food & Drug Administration ( USFDA) to market Quehapine Fumarate Tablets 25mg, 50mg, 100mg, 150mg, 200mg, 300mg and 400mg (ANDA 091388)
Quetiapine Fumarate Tablets 25mg, 50mg, 100mg, 150mg. 200mg, 300mg and 400mg are the generic equivalent of AstraZeneca LP’s Seroquel® Tablets 25mg, 50mg, 100mg. 150mg, 200mg, 300mg and 400mg. Quebapine Fumarate Tablets are indicated for the treatment of serious psychotic disorders such as Schizophrenia and Bipolar Disorder and falls under the Neurological (CNS) therapeutic category.
The product has been approved out of Unit III facility in Hyderabad, India Aurobindo now has a total of 147 ANDA approvals (118 Final approvals and 29 Tentative approvals) from USFDA
....more info